GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today shared the results of a study ...
Home care oxygen therapy provider Inogen Inc ( INGN) is expanding its manufacturing capacity. The company recently agreed to lease approximately 23,890 square feet area in Richardson, TX, which will ...
Inogen (INGN) remains unprofitable, with losses widening at a 31.9% annual rate over the past five years. Forecasts show its net profit margin is expected to stay negative for at least three more ...
This article first appeared on GuruFocus. Inogen Inc (NASDAQ:INGN) is set to release its Q3 2025 earnings on Nov 5, 2025. The consensus estimate for Q3 2025 revenue is $92.20 million, and the earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback